Summary
Dr. TJ Williams of the Institute of Natural Health introduces hyperbaric oxygen therapy (HBOT) in this first of a two-part series. He explains why HBOT remains underutilized in mainstream medicine, pointing to poorly designed studies that misled doctors about its effectiveness and the fact that over 75% of U.S. medical schools have no mention of hyperbaric medicine in their curriculum. Through an aspirin analogy, he illustrates how improper dosing in early studies unfairly branded HBOT as both worthless and dangerous. The episode covers the broad range of conditions HBOT can address, including traumatic brain injury, stroke, autism, neurologic diseases like MS and Alzheimer's, diabetes, cardiovascular disease, arthritis, chronic fatigue, cancer, and anti-aging. Williams emphasizes that inflammation is the common denominator in virtually all disease processes, and HBOT works by reducing that inflammatory fire. He also discusses how professional athletes use HBOT for faster recovery and how celebrities like Joe Namath have publicly advocated for the therapy. Williams introduces the foundational science behind HBOT, referencing Dr. Godman's 2008 research showing that a single one-hour treatment can affect over 8,000 genes (roughly 25% of the human genome) within 24 hours, turning on genes for growth and repair while turning off pro-inflammatory and cell death genes. He stresses that HBOT is a combination therapy requiring both increased pressure and concentrated oxygen to be effective.
Key Points
- Over 75% of U.S. medical schools have zero mention of hyperbaric oxygen therapy in their curriculum, leaving most doctors uninformed about its potential
- Poorly designed studies using incorrect dosing (too low or too high) unfairly branded HBOT as ineffective and dangerous, similar to what would have happened to aspirin under the same conditions
- A single one-hour HBOT treatment affects over 8,000 genes (~25% of the human genome), turning on growth and repair genes while turning off pro-inflammatory and cell death genes
- HBOT requires both increased pressure and concentrated oxygen to be effective — neither alone produces the same results
- The therapy can address a wide range of conditions including traumatic brain injury, stroke, MS, Alzheimer's, diabetes, cardiovascular disease, arthritis, cancer, and chronic fatigue
- Inflammation is the one factor common to all disease processes in the body, and HBOT works primarily by reducing this inflammatory response
- Professional athletes use HBOT chambers for faster recovery between training sessions and competitions
- The rising popularity of HBOT is largely patient-driven, with informed consumers seeking out the treatment after doing their own research
Key Moments
Hyperbaric therapy has been used since 1664 with growing scientific validation
Dr. TJ Williams notes that hyperbaric therapy dates back to 1664 in England, and despite centuries of use, mainstream medical acceptance has been slow, though the body of research validating its benefits has grown dramatically in recent years.
"From the beginning of hyperbaric therapy in England, which was way back in 1664, until just a couple of years ago, nobody really actually understood how hyperbaric treatment worked. And even people who knew that it did work, people like myself, were advocating for its use being expanded. We weren't exactly sure why it was working. But guess what? Now we know."
75% of medical schools have zero mention of hyperbaric medicine
Dr. Williams highlights that approximately 75% of medical schools do not include any mention of hyperbaric medicine in their curriculum, explaining why most doctors are uninformed about HBOT and may dismiss it despite strong evidence.
"could really help. But other than just those handful of applications, basically what we're saying is that hyperbaric oxygen therapy is largely unrecognized. And it's unrecognized, unfortunately, not because it doesn't work. It's unrecognized because nobody's actually wanting to understand it."
Poorly designed studies created lasting false narrative against HBOT
Dr. Williams explains how the reputation of HBOT was damaged by poorly designed studies that used incorrect dosages, drawing an analogy to testing a drug at half the recommended dose and then declaring it ineffective based on the predictably poor results.
"This is so important. What happens in research is researchers will design a study. It's not done very well. No one actually reads the study, let alone take it apart and dissect it, and see how the study was set up, how the study was run."
Earliest possible intervention is critical for brain injuries and concussions
Dr. Williams emphasizes that the key to maximizing HBOT benefits for brain injuries is earliest possible intervention, arguing that if someone gets a concussion, they should be in a hyperbaric chamber as soon as possible rather than waiting.
"treatment with hyperbaric oxygen therapy as soon as they possibly can after receiving the brain injury. If you get a concussion, you should be in a hyperbaric chamber."
